Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOXORUBICIN for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15,213 adverse event reports in the FDA FAERS database where DOXORUBICIN was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for DOXORUBICIN

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 8,844 10.7% 1,075 5,491
Off label use 7,858 9.5% 1,712 2,385
Disease progression 6,165 7.5% 1,384 865
Neutropenia 5,891 7.1% 927 2,104
Drug ineffective 4,598 5.6% 1,342 1,068
Pyrexia 3,697 4.5% 482 2,503
Thrombocytopenia 3,638 4.4% 645 1,330
Anaemia 3,601 4.4% 555 1,566
Product use in unapproved indication 3,502 4.2% 821 978
Nausea 2,925 3.5% 279 1,405
Sepsis 2,740 3.3% 1,481 1,198
Pneumonia 2,611 3.2% 839 1,521
Death 2,515 3.0% 2,514 299
Diarrhoea 2,330 2.8% 403 1,216
Vomiting 2,279 2.8% 310 1,233

Other Indications for DOXORUBICIN

Product used for unknown indication (5,186) Hodgkin's disease (4,606) B-cell lymphoma (3,947) Breast cancer (3,641) Non-hodgkin's lymphoma (3,298) Acute lymphocytic leukaemia (3,128) Plasma cell myeloma (2,820) Chemotherapy (1,756) Ovarian cancer (1,692) Lymphoma (1,420)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696) BENDAMUSTINE (3,538)

Related Pages

DOXORUBICIN Full Profile All Diffuse large b-cell lymphoma Drugs DOXORUBICIN Demographics DOXORUBICIN Timeline